Literature DB >> 16080710

Synthetic low-density lipoprotein, a novel biomimetic lipid supplement for serum-free tissue culture.

Sima Hayavi1, Gavin W Halbert.   

Abstract

Lipid supplementation in serum-free tissue culture employs solubilization techniques to permit the addition of lipids, but these systems are potentially cytotoxic and do not present lipid in a natural form. In this research a simplified preparation method for synthetic low-density lipoprotein (sLDL) has been developed that involves microfluidization of a solvent lipid solution in a simple aqueous solution. This produces material with size and zeta potential characteristics similar to those of native LDL. sLDL supplementation in tissue culture media provides cholesterol concentrations higher than those achieved by 10% serum supplementation and existing chemically defined lipid supplements. sLDL stimulates NS0 and U937 cellular proliferation in completely serum-free media, the former in a lipid concentration dependent manner that is also related to both the receptor peptide structure employed and its concentration on the particle. The greatest NS0 cellular proliferation was obtained at the highest cholesterol concentration tested (0.5 mg/mL), which was 10 times higher than the cholesterol concentration achieved by standard 10% serum supplementation. U937 cellular proliferation was influenced by variation of sLDL's fatty acid constituents with a natural mixture producing maximal effect. Cell uptake studies in NS0 with fluorescently labeled sLDL indicated that assimilation is reduced by competition from native LDL. The planktonic nature of NS0 cell growth meant that cell binding and uptake experiments were difficult to conduct because of cellular aggregation. However, sLDL-induced U937 proliferation is ablated by the presence of an anti-LDL receptor antibody. The results indicate that sLDL uptake is via the LDL receptor and that sLDL can function as a lipid supplement for serum-free media capable of supplementation to cholesterol concentrations up to 0.5 mg/mL. Cellular uptake studies also suggest that sLDL will be useful for the targeting and delivery of materials to cells. sLDL therefore represents a new and promising synthetic biomimetic alternative to native LDL with multiple applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080710     DOI: 10.1021/bp050043p

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  9 in total

1.  The role of recombinant proteins in the development of serum-free media.

Authors:  Joanne Keenan; Dermot Pearson; Martin Clynes
Journal:  Cytotechnology       Date:  2006-08-05       Impact factor: 2.058

Review 2.  Lipoprotein-based drug delivery.

Authors:  Sara Busatto; Sierra A Walker; Whisper Grayson; Anthony Pham; Ming Tian; Nicole Nesto; Jacqueline Barklund; Joy Wolfram
Journal:  Adv Drug Deliv Rev       Date:  2020-08-11       Impact factor: 15.470

3.  Low Density Lipid Nanoparticles for Solid Tumor Targeting.

Authors:  Mayank Shrivastava; Aviral Jain; Arvind Gulbake; Pooja Hurkat; Neeti Jain; R Vijayraghwan; Sanjay K Jain
Journal:  Sci Pharm       Date:  2014-08-28

Review 4.  Receptor-Mediated Drug Delivery Systems Targeting to Glioma.

Authors:  Shanshan Wang; Ying Meng; Chengyi Li; Min Qian; Rongqin Huang
Journal:  Nanomaterials (Basel)       Date:  2015-12-28       Impact factor: 5.076

5.  Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.

Authors:  Haiying Hua; Nan Zhang; Dan Liu; Lili Song; Tuanbing Liu; Shasha Li; Yongxing Zhao
Journal:  Int J Nanomedicine       Date:  2017-10-25

6.  Dhcr7 Regulates Palatal Shelf Fusion through Regulation of Shh and Bmp2 Expression.

Authors:  Wen-lin Xiao; Dai-zun Zhang; Hong Xu; Cui-zhu Zhuang
Journal:  Biomed Res Int       Date:  2016-03-15       Impact factor: 3.411

Review 7.  Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents.

Authors:  Skylar T Chuang; Siobanth Cruz; Vasanthy Narayanaswami
Journal:  Nanomaterials (Basel)       Date:  2020-05-08       Impact factor: 5.076

8.  LDL-mimetic lipid nanoparticles prepared by surface KAT ligation for in vivo MRI of atherosclerosis.

Authors:  Alessandro Fracassi; Jianbo Cao; Naoko Yoshizawa-Sugata; Éva Tóth; Corey Archer; Olivier Gröninger; Emanuela Ricciotti; Soon Yew Tang; Stephan Handschin; Jean-Pascal Bourgeois; Ankita Ray; Korinne Liosi; Sean Oriana; Wendelin Stark; Hisao Masai; Rong Zhou; Yoko Yamakoshi
Journal:  Chem Sci       Date:  2020-10-07       Impact factor: 9.825

Review 9.  Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.

Authors:  Xueqin Zhang; Gangliang Huang
Journal:  Drug Deliv       Date:  2017-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.